Disseminated molluscum contagiosum and pulmonary cryptococcosis coexisting in an HTLV-1 seropositive patient.
Adedayo
A O
AO
Bascom
C
C
Grell
G C
GC
Bellot
P
P
Adebiyi
R
R
Chandra
P
P
D000328:Adult; D000935:Antifungal Agents / Q000008:administration & dosage; D000998:Antiviral Agents / Q000008:administration & dosage; D001707:Biopsy, Needle; D003453:Cryptococcosis / Q000150:complications / Q000175:diagnosis* / Q000276:immunology; D004359:Drug Therapy, Combination; D005260:Female; D015490:HTLV-I Infections / Q000150:complications / Q000175:diagnosis* / Q000276:immunology; D015368:Human T-lymphotropic virus 1 / Q000302:isolation & purification*; D006801:Humans; D016867:Immunocompromised Host; D007150:Immunohistochemistry; D008172:Lung Diseases, Fungal / Q000150:complications / Q000175:diagnosis* / Q000276:immunology; D009894:Opportunistic Infections / Q000150:complications / Q000175:diagnosis* / Q000276:immunology; D011379:Prognosis; D018570:Risk Assessment; D012720:Severity of Illness Index
D000935:Antifungal Agents; D000998:Antiviral Agents